May 2024: Who bagged the biggest private biotech rounds?
This issue of our newsletter is supported by Lonza.
May 2024 was another relatively good month in terms of private biotech fundraising.
Although less money was raised overall than in April, May still saw the same amount of funding rounds take place, with 35 in total.
And an impressive $2.4 billion was raised from those rounds, making it the second-best month for fundraising of the year so far.
But which companies actually managed to bag the biggest rounds?
To find out more, read the full article: “The biggest private biotech investments in May 2024”
A MESSAGE FROM OUR SPONSOR LONZA
How to maximise cell line productivity and efficiency
What are the key considerations when developing CHO cell lines expressing novel biotherapeutics? How do you maximise productivity and efficiency, whilst minimising risk? Lonza expert, Dr. Tabitha Bullock, answers these essential questions and explains how Lonza’s technologies can help to ensure successful process and product development within accelerated timelines.
Recommended by LinkedIn
🔥 More noteworthy articles from this week:
The field of stem cell therapy has gained traction over recent years, with companies transitioning from experimental stages to delivering practical treatments. In this article, we take a look at eight stem cell-oriented biotech companies to know about.
The budding field of covalent biologics has made headway recently, as the only biotech pioneering the space, Enlaza Therapeutics, bagged $100 million in funding to move its pipeline to the clinic, which is primarily focused on antibody drug conjugates (ADCs).
Biotech career fairs are tailored for those who want to get into fields such as biotech, life science, and pharma investments, and attending them provides exposure and can get a job seeker’s foot in the door, especially when it comes to bagging an interview. Here, we explore six popular fairs that take place annually in the U.S.
Ohio has become an important hub for the biotech industry, thanks to a mix of strong educational institutions, a strategic location, and a supportive business enviroment. The state is home to a wide variety of biotech companies and research organizations, as this article focuses on the biotechs to know in Ohio.
As hearing loss has become a huge and growing global challenge, UK-based biotech company Rinri Therapeutics is developing a portfolio of off-the-shelf regenerative cell therapy products to address sensorineural hearing loss. In this episode, we have a conversation with Rinri CEO Simon Chandler.
By definition, rare diseases affect only a small number of patients. However, recruiting cohorts of sufficient size is not the only challenge in rare disease clinical trials. The lack of medicinal knowledge and ethical issues add to the complexity.
💡Enjoying these articles? Never miss a single publication of Labiotech by becoming a part of our community! Click here to join our mailing list.
Account Director at Optimum Strategic Communications
2moFantastic to see Pheon Therapeutics in the mix! Fantastic experienced team developing of pipeline of differentiated ADCs.